Detalhe da pesquisa
1.
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice.
Clin Infect Dis
; 77(12): 1626-1634, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556727
2.
Real-world evidence of survival benefit of remdesivir: study of 419 propensity score-matched patients hospitalized over the alpha and delta waves of COVID-19 in New Orleans, LA.
Front Med (Lausanne)
; 11: 1390164, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38818394